THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $98,000 | -66.8% | 10,300 | -74.1% | 0.00% | – |
| Q3 2021 | $295,000 | +46.0% | 39,700 | +305.1% | 0.00% | – |
| Q1 2021 | $202,000 | -63.8% | 9,800 | -54.6% | 0.00% | -100.0% |
| Q4 2019 | $558,000 | +174.9% | 21,600 | +74.1% | 0.00% | +100.0% |
| Q2 2019 | $203,000 | -46.3% | 12,409 | -20.5% | 0.00% | 0.0% |
| Q2 2018 | $378,000 | 0.0% | 15,600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $378,000 | -0.3% | 15,600 | +14.7% | 0.00% | 0.0% |
| Q4 2017 | $379,000 | -16.2% | 13,600 | +3.0% | 0.00% | -50.0% |
| Q3 2017 | $452,000 | +97.4% | 13,200 | +109.5% | 0.00% | +100.0% |
| Q1 2017 | $229,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |